首页> 外文期刊>International Journal of Cancer =: Journal International du Cancer >Inactivation of CHEK1 and EI24 is associated with the development of invasive cervical carcinoma: clinical and prognostic implications
【24h】

Inactivation of CHEK1 and EI24 is associated with the development of invasive cervical carcinoma: clinical and prognostic implications

机译:CHEK1和EI24的失活与浸润性宫颈癌的发展有关:临床和预后意义

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

To understand the importance of frequent deletion of chromosomal llq23.3-24.3 region in cervical carcinogenesis, alterations (deletion/methylation/mutation/expression) of the candidate genes LOH11CR2A, EI24 and CHEK1 located in the region were analyzed in 29 cervical intraepithelial neoplasia (CIN), 112 cervical carcinoma (CACX) samples and two CACX cell lines. The deletion frequency of these genes was low in CIN than in CACX [CIN: CHEK1: 28%, EI24: 21%, LOH11CR2A: 15% and CACX: CHEK1: 51%, EI24: 41%, LOH11CR2A: 36%]. Similar trend was seen in promoter methylation of these genes [CIN: CHEKl: 10%, EI24: 3%, LOH11CR2A: 3% and CACX: CHEKl: 55%, EI24: 31%, L0H11CR2A: 14%]. Mutations of the genes are a rare event. Overall alterations (deletion and methylation) of CHEKl and EI24 were associated with progression of CACX. Quantitative mRNA expression analysis showed reduced expression of the three genes in concordance to their molecular alterations. A shorter isoform of CHEKl lacking exon 8, hence impaired in substrate binding capacity, was found in two samples. Immunohistochemical analysis showed nuclear expression of Chek1, p-Chek1 and Ei24 in tumor tissues, whereas the cell lines exhibited both nuclear and cytoplasmic expression of Chekl and Ei24, as is also evident from Western blot analysis suggesting differential localization of the proteins. Alterations of CHEKl and EI24 coupled with tumor stage and early sexual debut (<19 years) predicted worst prognosis. Thus, our data suggest that inactivation of EI24 and CHEKl through two independent mechanisms contributes to the development of CACX.
机译:为了了解频繁缺失染色体llq23.3-24.3在宫颈癌发生中的重要性,在29例宫颈上皮内瘤变中分析了位于该区域的候选基因LOH11CR2A,EI24和CHEK1的改变(缺失/甲基化/突变/表达)( CIN),112个宫颈癌(CACX)样本和两个CACX细胞系。这些基因的缺失频率在CIN中比在CACX中低[CIN:CHEK1:28%,EI24:21%,LOH11CR2A:15%,CACX:CHEK1:51%,EI24:41%,LOH11CR2A:36%]。在这些基因的启动子甲基化中观察到相似的趋势[CIN:CHEK1:10%,EI24:3%,LOH11CR2A:3%和CACX:CHEK1:55%,EI24:31%,LOH11CR2A:14%]。基因突变是罕见的事件。 CHEK1和EI24的总体改变(缺失和甲基化)与CACX的进展有关。定量的mRNA表达分析显示,这三个基因的表达与其分子变化一致而减少。在两个样品中发现缺少外显子8的较短的CHEK1同工型,因此底物结合能力受损。免疫组织化学分析显示肿瘤组织中Chek1,p-Chek1和Ei24的核表达,而细胞系同时显示Chekl和Ei24的核表达和细胞质表达,这也可以从蛋白质印迹分析中看出,表明蛋白质的差异化定位。 CHEK1和EI24的改变与肿瘤分期和早期性行为首次出现(<19岁)预后最差。因此,我们的数据表明,通过两种独立的机制灭活EI24和CHEK1有助于CACX的发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号